Proteomics and genomics

Wojciech Rozek, Pawel S Ciborowski

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Successful completion of sequencing of the human genome showed considerably smaller number of genes (20,000 to 25,000 protein coding genes) (International Human Genome Sequencing Consortium. Lander ES, 2004) than expected and the number of proteins greatly exceeding the number of genes. This had a big impact on how we envision human and other proteomes and how we will approach proteomic and genomic analyses in the future. Isoforms, products of one gene modified by posttranslational modifications or alternative splicing, is only one part of complexity because function and biological role can also depend on cytoplasmic, subcellular compartments, and/or extracellular localization. Interactions with other proteins and nonproteinacious molecules add yet another layer of complexity.

Original languageEnglish (US)
Title of host publicationNeuroimmune Pharmacology
PublisherSpringer US
Pages725-741
Number of pages17
ISBN (Print)9780387725727
DOIs
StatePublished - Dec 1 2008

Fingerprint

Genomics
Proteomics
Human Genome
Genes
Proteins
Alternative Splicing
Proteome
Post Translational Protein Processing
Protein Isoforms

Keywords

  • 2 dimensional electrophoresis
  • Bioinformatics
  • Biomarker
  • Genomics
  • Neuroproteomics
  • Protein fi ngerprinting
  • Protein profi ling
  • Proteomics
  • Systems biology
  • Tissue profi ling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Rozek, W., & Ciborowski, P. S. (2008). Proteomics and genomics. In Neuroimmune Pharmacology (pp. 725-741). Springer US. https://doi.org/10.1007/978-0-387-72573-4_49

Proteomics and genomics. / Rozek, Wojciech; Ciborowski, Pawel S.

Neuroimmune Pharmacology. Springer US, 2008. p. 725-741.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rozek, W & Ciborowski, PS 2008, Proteomics and genomics. in Neuroimmune Pharmacology. Springer US, pp. 725-741. https://doi.org/10.1007/978-0-387-72573-4_49
Rozek W, Ciborowski PS. Proteomics and genomics. In Neuroimmune Pharmacology. Springer US. 2008. p. 725-741 https://doi.org/10.1007/978-0-387-72573-4_49
Rozek, Wojciech ; Ciborowski, Pawel S. / Proteomics and genomics. Neuroimmune Pharmacology. Springer US, 2008. pp. 725-741
@inbook{20dc699e579a4f319a673391d81230f0,
title = "Proteomics and genomics",
abstract = "Successful completion of sequencing of the human genome showed considerably smaller number of genes (20,000 to 25,000 protein coding genes) (International Human Genome Sequencing Consortium. Lander ES, 2004) than expected and the number of proteins greatly exceeding the number of genes. This had a big impact on how we envision human and other proteomes and how we will approach proteomic and genomic analyses in the future. Isoforms, products of one gene modified by posttranslational modifications or alternative splicing, is only one part of complexity because function and biological role can also depend on cytoplasmic, subcellular compartments, and/or extracellular localization. Interactions with other proteins and nonproteinacious molecules add yet another layer of complexity.",
keywords = "2 dimensional electrophoresis, Bioinformatics, Biomarker, Genomics, Neuroproteomics, Protein fi ngerprinting, Protein profi ling, Proteomics, Systems biology, Tissue profi ling",
author = "Wojciech Rozek and Ciborowski, {Pawel S}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-0-387-72573-4_49",
language = "English (US)",
isbn = "9780387725727",
pages = "725--741",
booktitle = "Neuroimmune Pharmacology",
publisher = "Springer US",

}

TY - CHAP

T1 - Proteomics and genomics

AU - Rozek, Wojciech

AU - Ciborowski, Pawel S

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Successful completion of sequencing of the human genome showed considerably smaller number of genes (20,000 to 25,000 protein coding genes) (International Human Genome Sequencing Consortium. Lander ES, 2004) than expected and the number of proteins greatly exceeding the number of genes. This had a big impact on how we envision human and other proteomes and how we will approach proteomic and genomic analyses in the future. Isoforms, products of one gene modified by posttranslational modifications or alternative splicing, is only one part of complexity because function and biological role can also depend on cytoplasmic, subcellular compartments, and/or extracellular localization. Interactions with other proteins and nonproteinacious molecules add yet another layer of complexity.

AB - Successful completion of sequencing of the human genome showed considerably smaller number of genes (20,000 to 25,000 protein coding genes) (International Human Genome Sequencing Consortium. Lander ES, 2004) than expected and the number of proteins greatly exceeding the number of genes. This had a big impact on how we envision human and other proteomes and how we will approach proteomic and genomic analyses in the future. Isoforms, products of one gene modified by posttranslational modifications or alternative splicing, is only one part of complexity because function and biological role can also depend on cytoplasmic, subcellular compartments, and/or extracellular localization. Interactions with other proteins and nonproteinacious molecules add yet another layer of complexity.

KW - 2 dimensional electrophoresis

KW - Bioinformatics

KW - Biomarker

KW - Genomics

KW - Neuroproteomics

KW - Protein fi ngerprinting

KW - Protein profi ling

KW - Proteomics

KW - Systems biology

KW - Tissue profi ling

UR - http://www.scopus.com/inward/record.url?scp=84900098145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900098145&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-72573-4_49

DO - 10.1007/978-0-387-72573-4_49

M3 - Chapter

SN - 9780387725727

SP - 725

EP - 741

BT - Neuroimmune Pharmacology

PB - Springer US

ER -